BTA Holders,
Please note correction to my earlier post-
Should read: It is bizarre that Biota has a US$231m (not $342m) grant from the US government to progress 2nd generation flu antiviral LANI through clinical trials and manufacture and yet BTA's market value sits at about AU$125m.
http://hotcopper.com.au/announcements.asp?id=286717
Kangaroo1